Open main menu

Psychiatrienet β

Tranylcypromine-fenelzine

Revision as of 15:32, 14 April 2026 by Joost (talk | contribs) (Created page with "{{Drugswitch | from = tranylcypromine | to = fenelzine | stop = {{generaldecrease25p3d}} {{7dWashout}} | start = *a wash-out period of 7 days is necessary. {{Startfenel}} |...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Tranylcypromine
Type Antidepressant
Group MAO-I
links
Medscape Tranylcypromine
PubChem 5530
PubMed Tranylcypromine
Kompas (Dutch) Tranylcypromine
Wikipedia Tranylcypromine
Fenelzine
Type Antidepressant
Group MAO-I
links
PubMed Fenelzine
Kompas (Dutch) Fenelzine
Wikipedia Fenelzine

Switch medication from tranylcypromine to fenelzine[1][2]

Nietinrijdenbord.png Stop tranylcypromine
  • Decrease with about 25% of original dose every 3 days
  • Stop and wait 7 days for washout
Eenrichtingbord.png Start fenelzine
  • a wash-out period of 7 days is necessary.
  • Start fenelzine in a low dosage of 15 mg, 3 times a day, for two weeks.
  • After this two weeks the dosage of fenelzine can be increased.
Letopbord.png Cave



  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.